- Home
- IFN vs EXAI Comparison
IFN vs EXAI Comparison
Compare IFN & EXAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IFN
- EXAI
- Stock Information
- Founded
- IFN 1993
- EXAI 2012
- Country
- IFN Singapore
- EXAI United Kingdom
- Employees
- IFN N/A
- EXAI N/A
- Industry
- IFN Finance/Investors Services
- EXAI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- IFN Finance
- EXAI Health Care
- Exchange
- IFN Nasdaq
- EXAI Nasdaq
- Market Cap
- IFN 666.1M
- EXAI 613.6M
- IPO Year
- IFN N/A
- EXAI 2021
- Fundamental
- Price
- IFN $16.75
- EXAI $4.84
- Analyst Decision
- IFN
- EXAI Hold
- Analyst Count
- IFN 0
- EXAI 4
- Target Price
- IFN N/A
- EXAI $7.00
- AVG Volume (30 Days)
- IFN 135.2K
- EXAI 828.8K
- Earning Date
- IFN 01-01-0001
- EXAI 11-08-2024
- Dividend Yield
- IFN 8.68%
- EXAI N/A
- EPS Growth
- IFN N/A
- EXAI N/A
- EPS
- IFN N/A
- EXAI N/A
- Revenue
- IFN N/A
- EXAI $22,877,630.00
- Revenue This Year
- IFN N/A
- EXAI $156.33
- Revenue Next Year
- IFN N/A
- EXAI N/A
- P/E Ratio
- IFN N/A
- EXAI N/A
- Revenue Growth
- IFN N/A
- EXAI N/A
- 52 Week Low
- IFN $14.40
- EXAI $3.80
- 52 Week High
- IFN $21.25
- EXAI $7.91
- Technical
- Relative Strength Index (RSI)
- IFN 30.60
- EXAI 44.03
- Support Level
- IFN $17.13
- EXAI $4.45
- Resistance Level
- IFN $17.92
- EXAI $4.85
- Average True Range (ATR)
- IFN 0.27
- EXAI 0.38
- MACD
- IFN -0.02
- EXAI -0.07
- Stochastic Oscillator
- IFN 5.13
- EXAI 19.12
About IFN India Fund Inc. (The)
India Fund Inc is an asset management company. The fund's investment objective is long-term capital appreciation, which it seeks to achieve by investing primarily in the equity securities of Indian companies. The company's portfolio is non-diversified closed-end management investment company across various sectors such as financials, consumer staples, information technology, materials, healthcare, consumer discretionary, industrials, telecommunication services, utilities and others. Geographically, all the business activity functions through the market of United States.
About EXAI Exscientia Plc
Exscientia PLC is engaged in the application of artificial intelligence (AI) and machine learning (ML) to the discovery and design of novel therapeutic compounds. The company's technology platform combines human and computational capabilities to accelerate the process of designing novel, safe, and efficacious compounds for clinical testing in humans. The company is focused on the discovery and development of small-molecule drug candidates.